Nailesh Bhatt Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

SONN Quotes by TradingView

Nailesh Bhatt is Director of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of SONN, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2025, when has been sold 10,547 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Nailesh Bhatt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2025
SELL
Sale (or disposition) back to the issuer
-
10,547 Reduced 100.0%
0 Common Stock
Jul 11 2025
BUY
Grant, award, or other acquisition
-
10,000 Added 48.67%
10,547 Common Stock
Dec 11 2023
BUY
Grant, award, or other acquisition
-
373 Added 40.54%
547 Common Stock
May 17 2023
BUY
Open market or private purchase
$5,750 $0.23 p/Share
25,000 Added 44.86%
30,733 Common Stock
Dec 14 2022
BUY
Grant, award, or other acquisition
-
3,770 Added 10.76%
31,255 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
14,152 Added 33.99%
27,485 Common Stock

Also insider at

PURR
Hyperliquid Strategies Inc
NB

Nailesh Bhatt

Director
Princeton,, NJ

Track Institutional and Insider Activities on SONN

Follow Sonnet BioTherapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SONN